Ok, I am the new kid on the block I guess, because I got into GNBT this year after doing some research and to be quite honest, have not regretted it one bit.

I have some other stocks in the same fields, so I understand what it takes to get drugs through the different phases and such.

That being said, my main focus is the uplist, because that will help push everything further along. And to that point, your information on the limitations of OTC makes sense and that is why patience with the drug testing to approval then to market is understandable and the uplist is the critical focal point right now.